Compared with other methods, slow tapering paired with psychological support may be effective for preventing remitted depression relapse.
Academics have identified the most effective method for discontinuing antidepressant medication, suggesting a gradual ...
Please provide your email address to receive an email when new articles are posted on . ATLANTA — Treatment with repeat doses of rituximab is superior to daily azathioprine for preventing relapse ...
MedPage Today on MSN
One Antidepressant Deprescribing Strategy Topped Others in Preventing Relapse
"Our findings suggest that while antidepressants are effective in preventing depressive relapses, they do not need to be a long-term treatment for everyone," co-author Debora Zaccoletti, PsyD, also of ...
John M. Kane, MD: When someone first develops a schizophrenia illness, I think one of our biggest challenges is helping that person to prevent the recurrence of a psychotic episode. Someone who ...
FILE PHOTO: Bottles of prescription painkillers Oxycodone Hydrochloride, 30mg, sit on a counter at a local pharmacy in Provo, Utah, April 25, 2017. REUTERS/George Frey/File Photo A good night’s sleep ...
A recent report by Buckley et al analyzed a previous study to determine the differences in second and third relapse rates in patients receiving long-acting injectable risperidone versus an oral second ...
For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that 1 ...
Please provide your email address to receive an email when new articles are posted on . Clozapine and second-generation long-acting formulations of certain antipsychotics decreased risk for ...
For people recovering from substance use, the holidays can disrupt routines and heighten the risk of relapsing. A prevention ...
Relapses can have devastating consequences for people with mental disorders such as schizophrenia, bipolar disorder, depression, or an anxiety disorder. After every relapse, it may become increasingly ...
Avelumab demonstrated a 53% response rate in chemo-resistant gestational trophoblastic tumors, with no relapse after 29 months of follow-up. The study suggests avelumab as a potential alternative to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results